Royalty Pharma (RPRX) Dividends Paid - Common (2019 - 2026)

Royalty Pharma (RPRX) has 8 years of Dividends Paid - Common data on file, last reported at $39.9 million in Q1 2026.

• For the quarter ending Q1 2026, Dividends Paid - Common fell 25.92% year-over-year to $39.9 million; the trailing twelve-month figure through Mar 2026 stood at $153.5 million (up 4.45% YoY), and the FY2025 full-year result was $167.5 million, up 33.81% from the prior year.
• Dividends Paid - Common fell to $39.9 million in Q1 2026, from $40.8 million in the prior quarter.
• In the past five years, Dividends Paid - Common ranged from a high of $53.8 million in Q1 2025 to a low of $24.5 million in Q4 2023.
• A 5-year average of $35.1 million and a median of $33.4 million in 2023 frame the typical range for Dividends Paid - Common.
• Peak annual rise in Dividends Paid - Common reached 114.4% in 2022, while the deepest fall reached 72.55% in 2022.
• Tracing RPRX's Dividends Paid - Common over 5 years: stood at $33.2 million in 2022, then dropped by 26.13% to $24.5 million in 2023, then climbed by 28.42% to $31.4 million in 2024, then grew by 29.6% to $40.8 million in 2025, then fell by 2.15% to $39.9 million in 2026.
• Business Quant data shows RPRX's Dividends Paid - Common at $39.9 million in Q1 2026, $40.8 million in Q4 2025, and $34.3 million in Q3 2025.